Jackson ImmunoResearch Laboratories
Private Company
Funding information not available
Overview
Jackson ImmunoResearch is a long-established, privately held manufacturer of secondary antibodies and detection reagents for immunological research. The company has built a strong reputation over four decades for product reliability, consistency, and technical support, serving a global customer base through a direct and distributor network. Its business model is focused on the research tools and reagents sector, generating revenue from the sale of its extensive catalog of conjugated antibodies and streptavidin products. The company is ISO 9001:2015 certified, emphasizing its commitment to quality management.
Technology Platform
Specialized platform for antibody purification, cross-adsorption, and conjugation to enzymes, fluorophores, and other reporters. Includes novel single-domain VHH (nanobody) fragment antibody technology for high-resolution applications.
Opportunities
Risk Factors
Competitive Landscape
Jackson ImmunoResearch competes in the crowded research antibodies and reagents market. Its primary competitors include large conglomerates like Thermo Fisher Scientific, Abcam (now part of Danaher), and Bio-Rad, as well as specialized secondary antibody producers such as Vector Laboratories and Rockland Immunochemicals. Its competitive differentiation is built on a decades-long reputation for high specificity (through cross-adsorption), consistency, and deep technical support in the secondary antibody niche.